TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva. July 13, 2007
TCL Archive House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick. November 14, 2008
TCL Archive NCAB Cool On CCOP, Ponders Questions On Distribution, Numbers Of Centers December 11, 1981